Metraipolis › archive › dc_73f1bb27de9e

An integrative neuropharmacological review of Huntington's disease challenges and the role of novel formulations in addressing pharmacological‒pharmaceutical… — Europe PMC PMID:42181874

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42181874
DOI
10.3389/fphar.2026.1794983
License (as archived)
solo-consultazione
Archived
2026-11-02T15:07:12.994Z
SHA-256 of the archived text
3dac86c7d419b4cc0b38f5a6a9da91dccc5e58b5ff9286b2afbc6e835a93d8ec
Stable URL of this page
https://metraipolis.com/documento/dc_73f1bb27de9e

How to cite

An integrative neuropharmacological review of Huntington's disease challenges and the role of novel formulations in addressing pharmacological‒pharmaceutical… — Europe PMC PMID:42181874 — Europe PMC (en), https://europepmc.org/article/MED/42181874 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_73f1bb27de9e (Metraipolis archive dc_73f1bb27de9e, sha256 3dac86c7d419b4cc0b38f5a6a9da91dccc5e58b5ff9286b2afbc6e835a93d8ec)
BibTeX
@misc{dc73f1bb27de9e,
  title = {An integrative neuropharmacological review of Huntington's disease challenges and the role of novel formulations in addressing pharmacological‒pharmaceutical… — Europe PMC PMID:42181874},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42181874},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_73f1bb27de9e; sha256 3dac86c7d419b4cc0b38f5a6a9da91dccc5e58b5ff9286b2afbc6e835a93d8ec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42181874. Agents can read the archived copy with the MCP tool read_document.